Not exact matches
New results from a clinical trial involving more than 900 military veterans at high risk for keratinocyte
carcinoma skin cancer provides evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may
reduce the risk of a
squamous cell carcinoma (SCC) needing surgery by 75 percent within a year.
So the group set out to test whether selenium might
reduce the chance of recurrence of basal
cell or
squamous cell carcinoma in people previously treated for skin cancer.
NSAID prescriptions were primarily associated with a
reduced risk of
squamous cell carcinoma and melanoma.